These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3322979)

  • 21. Total lymphoid irradiation in kidney and liver transplantation in the baboon: prolonged graft survival and alterations in T cell subsets with low cumulative dose regimens.
    Myburgh JA; Smit JA; Stark JH; Browde S
    J Immunol; 1984 Feb; 132(2):1019-25. PubMed ID: 6228586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent early immune response after kidney transplantation in patients of the European senior transplant program.
    Pratschke J; Merk V; Reutzel-Selke A; Pascher A; Denecke C; Lun A; Said A; Schönemann C; Ulrich F; Reinke P; Frei U; Neuhaus P; Tullius SG
    Transplantation; 2009 Apr; 87(7):992-1000. PubMed ID: 19352117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
    Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K
    Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Salvage therapy with anti-IL-2 receptor antibodies in high-risk kidney transplant patients].
    Carl S; Wiesel M; Deiss JM; Daniel V; Opelz G; Staehler G
    J Urol (Paris); 1997; 103(1-2):7-9. PubMed ID: 9765770
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term survival in living related donor renal allograft recipients with hepatitis B infection.
    Roy DM; Thomas PP; Dakshinamurthy KV; Jacob CK; Shastry JC
    Transplantation; 1994 Jul; 58(1):118-9. PubMed ID: 8036701
    [No Abstract]   [Full Text] [Related]  

  • 28. T-lymphocyte subsets in renal allograft recipients undergoing different immunosuppression protocols.
    Sumpio BE; Dwyer JM; Flye MW
    Curr Surg; 1986; 43(6):502-5. PubMed ID: 3542396
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical significance of early diagnose and treatment of subclinical renal allograft rejection].
    Zeng JH; Yu LX; Luo HH; Wang XC; Wang X; Fang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):697-8. PubMed ID: 16762888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
    Akalin E; Ames S; Sehgal V; Fotino M; Daly L; Murphy B; Bromberg JS
    Transplantation; 2003 Nov; 76(10):1444-7. PubMed ID: 14657683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
    Anderson CB; Sicard GA; Etheredge EE
    Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative administration of FTY720 prolonged renal allograft survival.
    Ueda H; Takahara S; Itoh S; Nomi H; Shibahara N; Katsuoka Y
    Transpl Immunol; 2005 Mar; 14(1):1-8. PubMed ID: 15814275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human dimeric tumor necrosis factor receptor (TNFR:Fc) as an immunosuppressive agent in renal allograft recipients.
    Eason JD; Wee SL; Kawai T; Hong HZ; Powelson J; Widmer M; Cosimi AB
    Transplant Proc; 1995 Feb; 27(1):554. PubMed ID: 7879095
    [No Abstract]   [Full Text] [Related]  

  • 34. Prednisolone half-life and T lymphocytes in renal allograft recipients.
    Walker KB; House AK; Maley MA; Potter JM
    Transplant Proc; 1985 Apr; 17(2):1679-81. PubMed ID: 3885504
    [No Abstract]   [Full Text] [Related]  

  • 35. Ratios of T lymphocyte subpopulations predict survival of cadaveric renal allografts in adult patients on low dose corticosteroid therapy.
    Van Es A; Tanke HJ; Baldwin WM; Oljans PJ; Ploem JS; Vanes LA
    Clin Exp Immunol; 1983 Apr; 52(1):13-20. PubMed ID: 6345032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro immunoresponsiveness in recipients of cadaveric renal allografts during ATG therapy.
    Grosse-Wilde H; Jakubowski HD; Eigler FW; Kuwert EK
    Proc Eur Dial Transplant Assoc; 1981; 18():481-5. PubMed ID: 7036170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single-dose daclizumab induction protocol in renal allograft recipients: a Chinese single center experience.
    Ji SM; Li LS; Cheng Z; Cheng DR; Sun QQ; Chen JS; Sha GZ; Liu ZH
    Transplant Proc; 2007 Jun; 39(5):1396-401. PubMed ID: 17580147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large granular lymphocyte subsets in long-term renal allograft recipients.
    Yip GH; Legendre CM; Rodrigues GA; Guttmann RD
    Transplant Proc; 1987 Aug; 19(4):3396-8. PubMed ID: 3303506
    [No Abstract]   [Full Text] [Related]  

  • 39. Review and preview of anti-T-cell antibodies.
    Helderman JH
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):8-9. PubMed ID: 7482824
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.
    Korczak-Kowalska G; Wierzbicki P; Bocian K; Klosowska D; Niemczyk M; Wyzgal J; Korecka A; Durlik M; Chmura A; Paczek L; Górski A
    Transplant Proc; 2007 Nov; 39(9):2721-3. PubMed ID: 18021968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.